Advertisement
PETS vs YI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETS is a Hold and YI is a StrongBuy.
PETS's RSI Oscillator climbs out of oversold territory
The RSI Indicator for PETS moved out of oversold territory on October 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 45 similar instances when the indicator left oversold territory. In 32 of the 45 cases the stock moved higher. This puts the odds of a move higher at 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 71 cases where PETS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for PETS just turned positive on October 20, 2026. Looking at past instances where PETS's MACD turned positive, the stock continued to rise in 32 of 47 cases over the following month. The odds of a continued upward trend are 68%.
PETS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for PETS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.151) is normal, around the industry mean (1.322). P/E Ratio (-0.891) is within average values for comparable stocks, (-2.118). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (0.984) as compared to the industry average of (0.246). P/S Ratio (0.200) is also within normal values, averaging (2.504).
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
YI's RSI Oscillator descends into oversold zone
The RSI Indicator for YI moved into overbought territory on October 23, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where YI advanced for three days, in 194 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
YI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on YI as a result. In 76 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for YI turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
YI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for YI crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for YI entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.219) is normal, around the industry mean (12.135). P/E Ratio (-0.237) is within average values for comparable stocks, (10.801). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.142) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. YI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
PETS | YI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 86 | 82 | |
P/E GROWTH RATING 1..100 | 13 | 18 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PETS's Valuation (5) in the Drugstore Chains industry is in the same range as YI (13). This means that PETS’s stock grew similarly to YI’s over the last 12 months.
PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as YI (100). This means that PETS’s stock grew similarly to YI’s over the last 12 months.
PETS's SMR Rating (98) in the Drugstore Chains industry is in the same range as YI (100). This means that PETS’s stock grew similarly to YI’s over the last 12 months.
YI's Price Growth Rating (82) in the Drugstore Chains industry is in the same range as PETS (86). This means that YI’s stock grew similarly to PETS’s over the last 12 months.
PETS's P/E Growth Rating (13) in the Drugstore Chains industry is in the same range as YI (18). This means that PETS’s stock grew similarly to YI’s over the last 12 months.
| PETS | YI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 71% | 2 days ago 86% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 81% |
| Momentum ODDS (%) | N/A | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 68% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| Advances ODDS (%) | N/A | 4 days ago 78% |
| Declines ODDS (%) | 3 days ago 84% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PETS’s FA Score shows that 2 FA rating(s) are green while YI’s FA Score has 2 green FA rating(s).
- PETS’s FA Score: 2 green, 3 red.
- YI’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PETS’s TA Score shows that 4 TA indicator(s) are bullish while YI’s TA Score has 4 bullish TA indicator(s).
- PETS’s TA Score: 4 bullish, 2 bearish.
- YI’s TA Score: 4 bullish, 6 bearish.
Price Growth
PETS (@Drugstore Chains) experienced а +3.39% price change this week, while YI (@Medical Distributors) price change was -7.77% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +14.65%. For the same industry, the average monthly price growth was -10.70%, and the average quarterly price growth was -50.74%.
The average weekly price growth across all stocks in the @Medical Distributors industry was -6.43%. For the same industry, the average monthly price growth was -9.59%, and the average quarterly price growth was -25.28%.
Reported Earning Dates
PETS is expected to report earnings on Nov 10, 2026.
YI is expected to report earnings on Dec 16, 2026.
Industries' Descriptions
@Drugstore Chains (+14.65% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
@Medical Distributors (-6.43% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
YI and
Correlation & Price change
A.I.dvisor tells us that YI and LFMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and LFMD's prices will move in lockstep.